about
Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patientsA novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesionA "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndromeSLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cellsCD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cellsStructural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cellsMeasles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation moleculeT helper cell activation and human retroviral pathogenesisMeasles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutininSoluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytesX-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cellsPredominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaquesMeasles immune suppression: lessons from the macaque modelStructure of the measles virus hemagglutinin bound to its cellular receptor SLAMThe Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) ProteinMeasles to the Rescue: A Review of Oncolytic Measles VirusMolecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2)Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene productBY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expressionA spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnessesDifferential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.Antagonistic pleiotropy and fitness trade-offs reveal specialist and generalist traits in strains of canine distemper virus.Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150)SLAM-family receptors: immune regulators with or without SAP-family adaptors.Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys.The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbillivirusesMorbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptorsCanine distemper virus infection requires cholesterol in the viral envelopeMeasles virus-induced suppression of immune responses.A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia.On guard--activating NK cell receptors.Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice.Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategiesThe cellular receptor for measles virus--elusive no more.
P2860
Q22010776-3EDE0EF5-B0DF-47CD-A9EE-F345FEEE9232Q24291489-624065D9-92B5-4768-A4C6-C6ECE2070020Q24292191-09A8830A-8F85-4459-A16C-0A90F9E6035AQ24292245-48A2511B-1803-4FD9-BFC3-7412AC087E52Q24297438-E83EC62D-8E45-46CB-88F3-CF4E1406C6CBQ24303493-927E8064-A30F-44AD-9735-C540D79DA5C5Q24535874-445B9D81-71EA-4F91-80A6-46F25CCCAB22Q24550615-24197493-4F26-473B-BE40-A3A25E3B5EAEQ24650854-41A4A7E0-AB6C-4C93-B6F0-F9F774604F00Q24655592-652D6897-979E-4077-89B3-ADB01661AAB1Q24669982-63260F12-5406-40AC-853C-39412EC68E0EQ24676168-8B2FBEEF-AB00-4565-AF85-4EB2638DB28CQ27319538-7C343CED-D853-4559-956E-9AFE408BF249Q27342799-E884DBA1-9642-4810-825D-91B3A8518712Q27666483-4BE89C42-4F02-4936-B40D-4EF91F2203F2Q28069519-C8AEE249-F004-4B4A-AA9E-CEF23E83CF57Q28072097-463AEF52-6FFA-4BCF-9CC2-12EF9AB472D3Q28142753-FD693533-D718-4F89-B346-79FD1CCABE15Q28181256-38973A6F-62D5-4E5F-86A2-75FE3A825D96Q28209604-1A206825-60D9-4C73-ADBE-C0635ED9E16AQ28215924-C0EEDA4A-3F73-4158-9FCD-2728C44CE698Q28216635-94CF56F1-1826-49D4-945F-DFC426C028BCQ28271106-FACFAEC9-25F6-4174-9608-9E9F4765279DQ30500838-B0653EB3-4558-4CCB-952E-1197D371C819Q30987804-4FB49D66-1727-4D3C-87E8-C54D82B5E987Q31109189-1B8F89D4-F6EE-4402-A87B-DEE0F26E721DQ33335355-61595445-5C90-455F-A6C2-04A0B49D1856Q33676460-075777A4-68D9-414B-B499-49BA73300F31Q33693795-AADCC294-DC4E-46D6-A728-2150FED96313Q33700550-9A93EFAA-6019-45C1-A6EA-A809806442EEQ33725565-3978C78B-9973-47C0-83FD-3C822038B308Q33820699-BEF407EF-C20F-4AF4-A701-29D58167B9A7Q33842243-B990658A-5728-4608-800E-7447BA5107A7Q34002204-62C35BBC-A17B-48E1-A37C-FAA5605FF1CBQ34015320-50685B42-F0C7-4B5C-A949-D31694A58C34Q34110002-2DA3594C-E8A8-400E-A73B-8428F28EB2A5Q34117069-F89EA606-9FE0-424C-A7D8-86F71B748681Q34132250-35044D03-2106-46A6-A072-386B4490250BQ34139647-9FDC78D7-DA19-4A45-B972-EF4B11CF49B7Q34263646-FA2D72DB-E88A-459C-A243-BC162E3FCE83
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A novel receptor involved in T-cell activation
@ast
A novel receptor involved in T-cell activation
@en
A novel receptor involved in T-cell activation
@en-gb
A novel receptor involved in T-cell activation
@nl
type
label
A novel receptor involved in T-cell activation
@ast
A novel receptor involved in T-cell activation
@en
A novel receptor involved in T-cell activation
@en-gb
A novel receptor involved in T-cell activation
@nl
prefLabel
A novel receptor involved in T-cell activation
@ast
A novel receptor involved in T-cell activation
@en
A novel receptor involved in T-cell activation
@en-gb
A novel receptor involved in T-cell activation
@nl
P2093
P3181
P356
P1433
P1476
A novel receptor involved in T-cell activation
@en
P2093
J E de Vries
J M Carballido
P2888
P3181
P356
10.1038/376260A0
P407
P577
1995-07-20T00:00:00Z
P6179
1021711997